Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

SMC Says Yes to Aubagio® (teriflunomide), a New Once Daily First-line Oral Treatment Available for People with an Active Relapsing Remitting Form of MS
FP187 – Oral Immunomodulatory Dimethyl Fumarate (DMF)
Episode 59 with Dr. Helmut Butzkueven on the new MS Brain Health initiative
International Society for Neurovascular Disease (ISNVD)
ACTRIMS-ECTRIMS 2014 -- Day 2, afternoon
FOCiS 2015 Meeting: Immunology by the Bay
ACTRIMS-ECTRIMS 2014 -- Day 3, afternoon
Mycophenolate mofetil for relapsing-remitting multiple sclerosis.
Remyelination in experimental models of toxin-induced demyelination.
Episode 42 with Dr. Lawrence Steinman on amyloid in experimental autoimmune encephalomyelitis
Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls.
Episode 44 with Dr. Monika Bradl on an animal model for neuromyelitis optica (NMO)
Episode 61 with Dr. Yanming Wang on molecular imaging of the myelin sheathing of axons
Episode 53: Part 1 with Dr. Jonathan Kipnis on the discovery of lymphatic vessels in the meninges
Improving the translational hit of experimental treatments in multiple sclerosis.
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
TECFIDERA® (dimethyl fumarate) approved in the European Union as a first-line oral treatment for multiple sclerosis
The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells.
Positive results from Phase 3 CONFIRM clinical trial show efficacy and safety of oral BG-12 in multiple sclerosis
Episode 55 with Dr. Michael Levy on the status of regenerative stem cell therapies for multiple sclerosis
Zist Daru, ZIFERON
Episode 62 with Dr. Ellen Mowry on vitamin D and caloric restriction for MS
Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.
Parenteral Dilantin®
Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder.

Pages